Sign in

CIK 0001422143

  • Non-accelerated filer
  • Smaller reporting company

Kura Oncology, Inc.

Sign in to watch
Ticker
KURA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
611547851
Phone
+1 858-500-8800
Business address
4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO, CA, 92121
Former names
ZETA ACQUISITION CORP III
Open-market buys, last 90 days
$4,248,530
in 3 filings
Open-market sales, last 90 days
$1,310,361
in 7 filings, $252K under 10b5-1 plans

Net +$2,938,169. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 38 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-11-16 WILSON TROY EDWARD President and CEO Purchase +101,119 $7.42 $750K 679,194
2026-11-16 WILSON TROY EDWARD President and CEO Purchase +101,119 $7.42 $750K 635,456
2026-11-13 WILSON TROY EDWARD President and CEO Purchase +98,881 $7.63 $754K 578,075
2026-11-13 WILSON TROY EDWARD President and CEO Purchase +98,881 $7.63 $754K 534,337
2026-09-29 FORD KATHLEEN Chief Operating Officer Sale 10b5-1 −3,668 $10.75 $39K 142,986
2026-09-29 Leoni Mollie Chief Medical Officer Sale −28,802 $10.75 $310K 141,095
2026-09-29 Powl Brian T. Chief Commercial Officer Sale −15,430 $10.75 $166K 136,819
2026-09-28 Bair Teresa Brophy Chief Legal Officer Sale 10b5-1 −8,442 $10.50 $89K 187,002
2026-09-28 FORD KATHLEEN Chief Operating Officer Sale 10b5-1 −6,906 $10.50 $72K 146,654
2026-09-28 Leoni Mollie Chief Medical Officer Sale −12,448 $10.50 $131K 169,897
2026-09-28 DOYLE THOMAS JAMES SVP, Finance & Accounting Sale −4,607 $10.50 $48K 142,428
2026-09-28 Powl Brian T. Chief Commercial Officer Sale −9,020 $10.50 $95K 160,249
2026-09-28 Powl Brian T. Chief Commercial Officer Sale −8,000 $10.56 $84K 152,249
2026-09-24 Burrows Francis Chief Scientific Officer Exercise or conversion +30,000 $6.15 $185K 63,053
2026-09-24 Burrows Francis Chief Scientific Officer Sale −20,726 $10.83 $225K 42,327
2026-09-24 Burrows Francis Chief Scientific Officer Exercise or conversion · Stock Option (Right to Buy) −30,000 0
2026-09-08 Fulk Jennifer Chief Financial Officer Grant or award · Option to purchase common stock 10b5-1 +450,000 450,000
2026-08-24 WILSON TROY EDWARD President and CEO Purchase +100,000 $12.39 $1.2M 479,194
2026-08-21 Powl Brian T. Chief Commercial Officer Sale 10b5-1 −4,345 $11.89 $52K 169,269
2026-08-19 Bair Teresa Brophy Chief Legal Officer Sale 10b5-1 −31,487 $12.63 $398K 195,444

Page 1 of 19 · 366 trades